China · Delayed Price · Currency is CNY Well Lead Medical Statistics
Total Valuation
SHA:603309 has a market cap or net worth of CNY 3.35 billion. The enterprise value is 3.55 billion.
| Market Cap | 3.35B |
| Enterprise Value | 3.55B |
Important Dates
The last earnings date was Friday, July 31, 2026.
| Earnings Date | Jul 31, 2026 |
| Ex-Dividend Date | May 28, 2026 |
Share Statistics
SHA:603309 has 291.87 million shares outstanding. The number of shares has decreased by -0.43% in one year.
| Current Share Class | 291.87M |
| Shares Outstanding | 291.87M |
| Shares Change (YoY) | -0.43% |
| Shares Change (QoQ) | +4.18% |
| Owned by Insiders (%) | 0.13% |
| Owned by Institutions (%) | 8.85% |
| Float | 142.57M |
Valuation Ratios
The trailing PE ratio is 58.53 and the forward PE ratio is 10.64.
| PE Ratio | 58.53 |
| Forward PE | 10.64 |
| PS Ratio | 2.03 |
| PB Ratio | 1.87 |
| P/TBV Ratio | 2.29 |
| P/FCF Ratio | 13.61 |
| P/OCF Ratio | 7.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.96, with an EV/FCF ratio of 14.41.
| EV / Earnings | 62.03 |
| EV / Sales | 2.15 |
| EV / EBITDA | 9.96 |
| EV / EBIT | 13.14 |
| EV / FCF | 14.41 |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.35.
| Current Ratio | 1.74 |
| Quick Ratio | 1.30 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 1.74 |
| Debt / FCF | 2.52 |
| Interest Coverage | 15.75 |
Financial Efficiency
Return on equity (ROE) is 3.72% and return on invested capital (ROIC) is 8.49%.
| Return on Equity (ROE) | 3.72% |
| Return on Assets (ROA) | 6.10% |
| Return on Invested Capital (ROIC) | 8.49% |
| Return on Capital Employed (ROCE) | 12.11% |
| Weighted Average Cost of Capital (WACC) | 2.98% |
| Revenue Per Employee | 580,856 |
| Profits Per Employee | 20,095 |
| Employee Count | 2,849 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 4.70 |
Taxes
In the past 12 months, SHA:603309 has paid 40.72 million in taxes.
| Income Tax | 40.72M |
| Effective Tax Rate | 37.43% |
Stock Price Statistics
The stock price has decreased by -20.21% in the last 52 weeks. The beta is -0.16, so SHA:603309's price volatility has been lower than the market average.
| Beta (5Y) | -0.16 |
| 52-Week Price Change | -20.21% |
| 50-Day Moving Average | 11.87 |
| 200-Day Moving Average | 13.61 |
| Relative Strength Index (RSI) | 44.02 |
| Average Volume (20 Days) | 4,513,892 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603309 had revenue of CNY 1.65 billion and earned 57.25 million in profits. Earnings per share was 0.20.
| Revenue | 1.65B |
| Gross Profit | 716.98M |
| Operating Income | 270.27M |
| Pretax Income | 108.80M |
| Net Income | 57.25M |
| EBITDA | 346.20M |
| EBIT | 270.27M |
| Earnings Per Share (EPS) | 0.20 |
Balance Sheet
The company has 434.60 million in cash and 619.92 million in debt, with a net cash position of -185.32 million or -0.63 per share.
| Cash & Cash Equivalents | 434.60M |
| Total Debt | 619.92M |
| Net Cash | -185.32M |
| Net Cash Per Share | -0.63 |
| Equity (Book Value) | 1.79B |
| Book Value Per Share | 6.09 |
| Working Capital | 362.90M |
Cash Flow
In the last 12 months, operating cash flow was 456.63 million and capital expenditures -210.20 million, giving a free cash flow of 246.44 million.
| Operating Cash Flow | 456.63M |
| Capital Expenditures | -210.20M |
| Depreciation & Amortization | 75.93M |
| Net Borrowing | -23.03M |
| Free Cash Flow | 246.44M |
| FCF Per Share | 0.84 |
Margins
Gross margin is 43.33%, with operating and profit margins of 16.33% and 3.46%.
| Gross Margin | 43.33% |
| Operating Margin | 16.33% |
| Pretax Margin | 6.57% |
| Profit Margin | 3.46% |
| EBITDA Margin | 20.92% |
| EBIT Margin | 16.33% |
| FCF Margin | 14.89% |
Dividends & Yields
This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 5.22%.
| Dividend Per Share | 0.60 |
| Dividend Yield | 5.22% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 276.36% |
| Buyback Yield | 0.43% |
| Shareholder Yield | 5.65% |
| Earnings Yield | 1.71% |
| FCF Yield | 7.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 25, 2020. It was a forward split with a ratio of 1.3.
| Last Split Date | May 25, 2020 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
SHA:603309 has an Altman Z-Score of 4.14 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.14 |
| Piotroski F-Score | 6 |